Search Results - Beydoun, Tammam

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    First in-human, intracisternal dosing of RGX-111, an investigational AAV gene therapy, for a 21-month-old child with mucopolysaccharidosis type I (MPS I): 3.5 year follow-up

    First in-human, intracisternal dosing of RGX-111, an investigational AAV gene therapy, for a 21-month-old child with mucopolysaccharidosis type I (MPS I): 3.5 year follow-up by Wang, Raymond Y., Movsesyan, Nina, Kan, Shih-hsin, Beydoun, Tammam, Taylor, Mery, Chang, Richard C., Phillips, Dawn, Burke, Jenna, Gilmor, Michelle, Cho, Yoonjin, Falabella, Paulo, Pisani, Laura

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    First in-human intracisternal dosing of RGX-111 (adeno-associated virus 9/human α-L-iduronidase) for a 20-month-old child with mucopolysaccharidosis type I (MPS I): 1 year follow-up

    First in-human intracisternal dosing of RGX-111 (adeno-associated virus 9/human α-L-iduronidase) for a 20-month-old child with mucopolysaccharidosis type I (MPS I): 1 year follow-u... by Wang, Raymond Y., Beydoun, Tammam, Movsesyan, Nina, Kan, Shih-Hsin, Taylor, Mery, Stockton, Winnie, Nestrasil, Igor, Pukenas, Bryan, Falabella, Paulo, Cho, Yoonjin, Névoret, Marie-Laure

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: